Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Leukemia

Free Subscription 04.06.2018 2 Ann Hematol 4 Blood 1 BMC Cancer 2 Bone Marrow Transplant 2 Cancer 1 Cancer Chemother Pharmacol 1 Cancer Lett 1 Cell 1 Exp Hematol 1 Int J Hematol 3 J Clin Oncol 1 J Pediatr Hematol Oncol 3 N Engl J Med 1 Oncol Rep 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Hematol

1. IWASHIGE A, Hirosawa M, Tsukada J
   Hairy cell leukemia presenting with progressive pericarditis and pleuritis.
   Ann Hematol. 2018 May 30. pii: 10.1007/s00277-018-3378.
   PubMed     Text format    
   
   
2. MOLICA M, Scalzulli E, Colafigli G, Fegatelli DA, et al
   Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events.
   Ann Hematol. 2018 May 27. pii: 10.1007/s00277-018-3375.
   PubMed     Text format     Abstract available
   
   

   
   Blood

3. PATEL SS, Dorfman DM
   Leukemic-phase progression of aleukemic mast cell leukemia.
   Blood. 2018;131:2406.
   PubMed     Text format    
   
   
4. ALDOSS I, Song JY
   Extramedullary relapse of KMT2A(MLL)-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab.
   Blood. 2018;131:2507.
   PubMed     Text format    
   
   
5. LEBLANC TW, Egan PC, Olszewski AJ
   Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia.
   Blood. 2018 May 30. pii: blood-2018-03-842575. doi: 10.1182/blood-2018-03-842575
   PubMed     Text format     Abstract available
   
   
6. MELO-CARDENAS J, Xu Y, Wei J, Tan C, et al
   USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1 dependent mechanism.
   Blood. 2018 May 29. pii: blood-2017-10-811760. doi: 10.1182/blood-2017-10-811760
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

7. LI F, Zhang X, Wang Y, Yang A, et al
   Haemophagocytic lymphohistiocytosis occurred during induction chemotherapy in an acute monocytic leukemia patient with FLT3-ITD and DNMT3A mutations.
   BMC Cancer. 2018;18:604.
   PubMed     Text format     Abstract available
   
   

   
   Bone Marrow Transplant

8. CRADDOCK C, Hoelzer D, Komanduri KV
   Current status and future clinical directions in the prevention and treatment of relapse following hematopoietic transplantation for acute myeloid and lymphoblastic leukemia.
   Bone Marrow Transplant. 2018 May 31. pii: 10.1038/s41409-018-0203.
   PubMed     Text format     Abstract available
   
   
9. KATO M, Kurata M, Kanda J, Kato K, et al
   Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemia.
   Bone Marrow Transplant. 2018 May 24. pii: 10.1038/s41409-018-0221.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

10. ARELLANO M, Carlisle JW
    How I treat older patients with acute myeloid leukemia.
    Cancer. 2018 May 29. doi: 10.1002/cncr.31347.
    PubMed     Text format    
    
    
11. GORDON MJ, Churnetski M, Alqahtani H, Rivera X, et al
    Comorbidities predict inferior outcomes in chronic lymphocytic leukemia treated with ibrutinib.
    Cancer. 2018 May 24. doi: 10.1002/cncr.31554.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Chemother Pharmacol

12. GAO C, Hu S, Guo M, Hai X, et al
    Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia.
    Cancer Chemother Pharmacol. 2018 May 29. pii: 10.1007/s00280-018-3606.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

13. ZHANG X, Zheng X, Yang H, Yan J, et al
    Piribedil disrupts the MLL1-WDR5 interaction and sensitizes MLL-rearranged acute myeloid leukemia (AML) to doxorubicin-induced apoptosis.
    Cancer Lett. 2018 May 29. pii: S0304-3835(18)30367.
    PubMed     Text format     Abstract available
    
    

    
    Cell

14. KIM MY, Yu KR, Kenderian SS, Ruella M, et al
    Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.
    Cell. 2018;173:1439-1453.
    PubMed     Text format     Abstract available
    
    

    
    Exp Hematol

15. NICOLINI FE, Alcazer V, Cony-Makhoul P, Heiblig M, et al
    Long-term follow-up of de novo chronic phase chronic myelogenous leukemia patients on imatinib first-line.
    Exp Hematol. 2018 May 22. pii: S0301-472X(18)30259.
    PubMed     Text format     Abstract available
    
    

    
    Int J Hematol

16. SATO K, Sakai H, Saiki Y, Uchida A, et al
    Cell dynamics during differentiation therapy with all-trans retinoic acid in acute promyelocytic leukemia.
    Int J Hematol. 2018 May 29. pii: 10.1007/s12185-018-2472.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

17. ROSS DM, Burbury KL, Grigg AP, Hughes TP, et al
    Management of Pregnancy in Women With Chronic Myeloid Leukemia.
    J Clin Oncol. 2018 May 31:JCO2018786137. doi: 10.1200/JCO.2018.78.6137.
    PubMed     Text format    
    
    
18. VAREDI M, Lu L, Howell CR, Partin RE, et al
    Peripheral Neuropathy, Sensory Processing, and Balance in Survivors of Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2018 May 29:JCO2017767871. doi: 10.1200/JCO.2017.76.7871.
    PubMed     Text format     Abstract available
    
    
19. SLAYTON WB, Schultz KR, Kairalla JA, Devidas M, et al
    Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.
    J Clin Oncol. 2018 May 29:JCO2017767228. doi: 10.1200/JCO.2017.76.7228.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr Hematol Oncol

20. VEDI A, Mitchell R, Shanmuganathan S, Oswald C, et al
    Increased Survival for Children With Acute Myeloid Leukemia Results From Improved Postrelapse Treatment.
    J Pediatr Hematol Oncol. 2018 May 22. doi: 10.1097/MPH.0000000000001215.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

21. COPUR MS, Gauchan D, Crockett D
    Venetoclax-Rituximab in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2018;378:2142-3.
    PubMed     Text format    
    
    
22. FERHANOGLU B, Ozturk E, Ozbalak M
    Venetoclax-Rituximab in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2018;378:2141-2.
    PubMed     Text format    
    
    
23. 
    Venetoclax-Rituximab in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2018;378:2141-2144.
    PubMed     Text format    
    
    

    
    Oncol Rep

24. ZOVKO A, Yektaei-Karin E, Salamon D, Nilsson A, et al
    Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
    Oncol Rep. 2018 May 25. doi: 10.3892/or.2018.6465.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

25. KSIONDA O, Mues M, Wandler AM, Donker L, et al
    Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy.
    PLoS One. 2018;13:e0193849.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: